Skip to content

Group psychotherapy for older adults with personality disorders: effectiveness and costs

Group schema-focused therapy enriched with psychomotor therapy for older adults with personality disorders in specialized mental health care: A (cost-) effectiveness study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25581
Enrollment
140
Registered
2017-07-28
Start date
2017-08-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental disorder, Personality disorder

Interventions

Group Schema Focused Therapy enriched with psychomotor therapy will be delivered in eighteen weekly and two follow-up sessions (at weeks 22 and 26), consisting of 2h group Schema Focused Therapy and 1

Sponsors

University Medical Center Groningen, Department of Psychiatry, Groningen, The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age 60 years or older. - Cluster B or C personality or meeting the general diagnostic criteria for a personality disorder falling short one content criterion for a specific cluster B or C personality disorder. - Mentally able to adhere to the group schema-focused treatment schedule and to fill out schema (mode) questionnaires. - Informed consent after having received oral and written information.

Exclusion criteria

Exclusion criteria: - Severe mental illness, including current bipolar disorder, psychosis, or substance abuse disorders needing clinical detoxification. - An established neurodegenerative disorder. - Cognitive impairment defined as a MoCA sum score below 24 points. - Prior schema-focused therapy, received in the previous year or during the present episode of illness. - Immediate suicide risk interfering with adequate treatment delivery.

Design outcomes

Primary

MeasureTime frame
Primary outcome is psychological distress, as assessed with the Brief Symptom Inventory- 53 item version (BSI-53). For cost-effectiveness analysis, health related quality of life is assessed with the EuroQoL; EQ-5D-5L, and medical consumption and other cost data are gathered by structured patient interview.

Secondary

MeasureTime frame
Secondary outcome measures are: 1) life satisfaction, 2) mental wellbeing, 3) personality functioning, 4) interoceptive body awareness, 5) psychotropic drug use and treatment received, and 6) mood variability.

Contacts

Public ContactM.S. Veenstra

University Medical Center Groningen, Department of Psychiatry

m.s.veenstra@umcg.nl+31 50 3612079

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)